These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 31005943)
1. Could implementation of mifepristone address Canada's urban-rural abortion access disparity: a mixed-methods implementation study protocol. Norman WV; Munro S; Brooks M; Devane C; Guilbert E; Renner R; Kendall T; Soon JA; Waddington A; Wagner MS; Dunn S BMJ Open; 2019 Apr; 9(4):e028443. PubMed ID: 31005943 [TBL] [Abstract][Full Text] [Related]
2. Barriers and Facilitators to the Implementation of First Trimester Medical Abortion With Mifepristone in the Province of Québec: A Qualitative Investigation. Wagner MS; Munro S; Wilcox ES; Devane C; Norman WV; Dunn S; Soon JA; Guilbert É J Obstet Gynaecol Can; 2020 May; 42(5):576-582. PubMed ID: 31924442 [TBL] [Abstract][Full Text] [Related]
3. Pharmacist dispensing of the abortion pill in Canada: Diffusion of Innovation meets integrated knowledge translation. Munro S; Wahl K; Soon JA; Guilbert E; Wilcox ES; Leduc-Robert G; Ansari N; Devane C; Norman WV Implement Sci; 2021 Aug; 16(1):76. PubMed ID: 34344393 [TBL] [Abstract][Full Text] [Related]
4. A Virtual Community of Practice to Support Physician Uptake of a Novel Abortion Practice: Mixed Methods Case Study. Dunn S; Munro S; Devane C; Guilbert E; Jeong D; Stroulia E; Soon JA; Norman WV J Med Internet Res; 2022 May; 24(5):e34302. PubMed ID: 35511226 [TBL] [Abstract][Full Text] [Related]
5. Exploring Canadian women's knowledge of and interest in mifepristone: results from a national qualitative study with abortion patients. Vogel KI; LaRoche KJ; El-Haddad J; Chaumont A; Foster AM Contraception; 2016 Aug; 94(2):137-42. PubMed ID: 27125893 [TBL] [Abstract][Full Text] [Related]
6. Slow implementation of mifepristone medical termination of pregnancy in Quebec, Canada: a qualitative investigation. Guilbert E; Wagner MS; Munro S; Wilcox ES; Dunn S; Soon JA; Devane C; Norman WV Eur J Contracept Reprod Health Care; 2020 Jun; 25(3):190-198. PubMed ID: 32312130 [No Abstract] [Full Text] [Related]
7. Implementation of mifepristone medical abortion in Canada: pilot and feasibility testing of a survey to assess facilitators and barriers. Devane C; Renner RM; Munro S; Guilbert É; Dunn S; Wagner MS; Norman WV Pilot Feasibility Stud; 2019; 5():126. PubMed ID: 31720004 [TBL] [Abstract][Full Text] [Related]
8. Perspectives Among Canadian Physicians on Factors Influencing Implementation of Mifepristone Medical Abortion: A National Qualitative Study. Munro S; Guilbert E; Wagner MS; Wilcox ES; Devane C; Dunn S; Brooks M; Soon JA; Mills M; Leduc-Robert G; Wahl K; Zannier E; Norman WV Ann Fam Med; 2020 Sep; 18(5):413-421. PubMed ID: 32928757 [TBL] [Abstract][Full Text] [Related]
9. Integrating mifepristone into primary care in Canada's capital: A multi-methods exploration of the Medical Abortion Access Project. LaRoche KJ; Wylie A; Persaud M; Foster AM Contraception; 2022 May; 109():37-42. PubMed ID: 35031301 [TBL] [Abstract][Full Text] [Related]
10. Can youth-engaged research facilitate equitable access to contraception in Canada? The qualitative study protocol for the Ask Us project. Munro S; Di Meglio G; Williams A; Barbic SP; Begun S; Black A; Carson A; Fortin M; Jacob K; Khan Z; Martin-Misener R; Meherali S; Paller V; Seiyad H; Vallée CA; Wahl K; Norman WV BMJ Open; 2023 Mar; 13(3):e070904. PubMed ID: 36863736 [TBL] [Abstract][Full Text] [Related]
11. Towards safe abortion access: an exploratory study of medical abortion in Cambodia. Petitet PH; Ith L; Cockroft M; Delvaux T Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):47-55. PubMed ID: 25702068 [TBL] [Abstract][Full Text] [Related]
12. Pharmacist direct dispensing of mifepristone for medication abortion in Canada: a survey of community pharmacists. Zusman EZ; Munro S; Norman WV; Soon JA BMJ Open; 2022 Oct; 12(10):e063370. PubMed ID: 36207038 [TBL] [Abstract][Full Text] [Related]
13. Early medical abortion in India: three studies and their implications for abortion services. Coyaji K J Am Med Womens Assoc (1972); 2000; 55(3 Suppl):191-4. PubMed ID: 10846337 [TBL] [Abstract][Full Text] [Related]
14. "They made me go through like weeks of appointments and everything": Documenting women's experiences seeking abortion care in Yukon territory, Canada. Cano JK; Foster AM Contraception; 2016 Nov; 94(5):489-495. PubMed ID: 27373541 [TBL] [Abstract][Full Text] [Related]
15. Patients' Motivation for Surgical Versus Medical Abortion. Murray ME; Casson M; Pudwell J; Waddington A J Obstet Gynaecol Can; 2019 Sep; 41(9):1325-1329. PubMed ID: 30878325 [TBL] [Abstract][Full Text] [Related]
16. Expanding access to medical abortion: challenges and opportunities. Ganatra B; Guest P; Berer M Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):1-3. PubMed ID: 25702063 [No Abstract] [Full Text] [Related]
17. "We've got rights and yet we don't have access": Exploring patient experiences accessing medication abortion in Australia. LaRoche KJ; Wynn LL; Foster AM Contraception; 2020 Apr; 101(4):256-260. PubMed ID: 31927029 [TBL] [Abstract][Full Text] [Related]
18. Feasibility, efficacy, safety, and acceptability of mifepristone-misoprostol for medical abortion in the Democratic People's Republic of Korea. Tran NT; Jang MC; Choe YS; Ko WS; Pyo HS; Kim OS Int J Gynaecol Obstet; 2010 Jun; 109(3):209-12. PubMed ID: 20206354 [TBL] [Abstract][Full Text] [Related]
19. Abortion Stigma as a Barrier to Mifepristone Use among Obstetrician-Gynecologists in Alabama for Early Pregnancy Loss. Mokashi M; Boulineaux C; Janiak E; Boozer M; Neill S South Med J; 2024 Aug; 117(8):504-509. PubMed ID: 39094802 [TBL] [Abstract][Full Text] [Related]
20. General practitioner knowledge and practice in relation to unintended pregnancy in the Grampians region of Victoria, Australia. Keogh L; Croy S; Newton D; Hendron M; Hill S Rural Remote Health; 2019 Nov; 19(4):5156. PubMed ID: 31675244 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]